8
Views
0
CrossRef citations to date
0
Altmetric
Literature Alerts

Literature Alerts

Pages 123-135 | Published online: 27 Sep 2008

LITERATURE ALERTS

  • Choosing and using a pancreatic enzyme supplement. Drug Ther. Bull., 1992, 30, (10), 37–40.
  • Controlled-release vaccines-biodegradable polylactide/polyglycolide (PL/PG) microspheres as antigen vehicles. AGUADO, M. T., and LAMBERT, P. H., Immunobiology, 1992, 184, (2-3), 113–125.
  • Tissue distribution and antileishmanial activity of liposomized amphotericin-B in Balb/c mice. AHMAD, I., AGARWAL, A., PAL, A., GURU, P. Y., BACHHAWAT, B. K., and GUPTA, C. M., J. Biosci., 1991, 16, (4), 217–221.
  • Liposomal delivery system for the targeting and controlled release of praziquantel. AKBARIEH, M., BESNER, J. G., GALAL, A., and Taw/km-II, R., Drug Dev. Ind. Pharm., 1992, 18, (3), 303–317.
  • Some factors affecting properties and dissolution behavior of tableted furosemide micro- spheres. AKBUGA, J., Pharmazie, 1992, 47, (2), 128–131.
  • Stealth liposomes: an improved sustained release system for 1-beta-n-arabino-furanosylcytosine. ALLEN, T. M., MEHRA, T., HANSEN, C., and CHIN, Y. C., Cancer Res., 1992, 52, (9), 2431–2439.
  • Liposomes containing lipid A as a potent nontoxic adjuvant. ALA/LNG, C. R., VERMA, J. N., RAO, M., KRZYCH, U., AMSELEM, S., GREEN, S. M, and WASSEF, N. M., Res. Immunol., 1992, 143, (2), 197–198.
  • Effect of liposomal superoxide dismutase on tourniquet shock in rabbits. AoKI, Y., NATA, M., ODAIRA, T., and SAGISAKA, K., Hanzaigaku Zasshi, 1991, 57, (6), 215–222.
  • Acetyl-L-carnitine influences the fluidity of brain microsomes and of liposomes made of rat brain microsomal lipid extracts. ARIENTI, G., RAMACCI, M. T., MACCARI, F., CASU, A., and CORAZZI, L., Neurochem. Res., 1992, 17, (7), 671–675.
  • Slow photoprocesses in liposomes dispersion. ARISTARKHOV, V. M., Biofizika, 1992, 37, (1), 73–78.
  • Efficacy of liposome entrapped allergen in down regulation of IgE response in mice. ARORA, N., and GANGAL, S. V., Clin. Exp. Allergy, 1992, 22, (1), 35–42.
  • Naming microcapsules. ARSHADY, R., J. Microencapsulation, 1992, 9, (2), 187–190.
  • Activity of free and liposome encapsulated streptomycin against Mycobacterium avium complex (MAC) inside peritoneal macrophages. ASHTEKAR, D., DUZGUNES, N., and GANGADHARAM, P. R. J., J. Antimicrob. Chemother., 1991, 28, (4), 615–617.
  • Inhibition of liposomal lipid peroxidation by spermidine. AWASTHI, S., KAKKAR, P., and VISWANATHAN, P. N., J. Microencapsulation, 1992, 9, (2), 237–242.
  • Staphylococcus aureus microcapsule expression attenuates bacterial virulence in a rat model of experimental endocarditis. BADDOIJR, L. M., LOWRANCE, C., ALBUS, A., LOWRANCE, J. H., ANDERSON, S. K., and LEE, J. C., J. Infect. Dis., 1992, 165, (4), 749–753.
  • Enhanced localization of liposomes with prolonged blood circulation time in infected tissue. BAKKER-WOUDENBERG, I. A., LOKERSE, A. F., TEN-KATE, M. I., and STORM, G., Biochim. Biophys. Acta, 1992, 1138, (4), 318–326.
  • Reaction of ozone with glycophorin in solution and in lipid vesicles. BANNERJEE, S. K., and MUDD, J. B., Arch. Biochem. Biophys., 1992, 295, (1), 84–89.
  • Immunologic reaction of human recipients to repeated exposures to Albunex microspheres. BARNHART, J. L., HARADA, M., LYLE, L. R., and SARAV1S, C. A., Invest. Radiol., 1991,26 (Suppl. 1), S192-S193; discussion S198–S200.
  • Theory of paramagnetic contrast agents in liposome systems. BARSKY, D., PUTS, B., SCHULTEN, K., and MAGIN, R. L., Magn. Reson. Med., 1992, 24, (1), 1–13.
  • The direct determination of protein concentration for proteins immobilized on polystyrene microspheres. BASINSKA, T., and SLOMKOWSKI, S., J. Biomater. Sci., Polym. Ed., 1991, 3, (2), 115–125.
  • A simple production method for liposomes and experimental production of hemoglobin and insulin liposomes. An overview of a series of experiments for production of lipsomes intended for parenteral and preoral administration. BAUER, K. H., Pharm. Unserer. Zeit., 1992, 21, (2), 71–75.
  • Evaluation of antibody-bearing liposomal amphotericin B in the treatment of systemic candidiasis in a neutropenic murine model. BELAY, T., HOSPHENTHAL, D. R., ROGERS, A. L., and PATTERSON, M. J., J. Med. Vet. Mycol., 1991, 29, (6), 419–421.
  • Drug encapsulation and release from multilamellar and unilamellar liposomes. BETAGERI, G. V., and PARSONS, D. L., Int. J. Pharm., 1992, 81, (2-3), 235–241.
  • A biodegradable testosterone microcapsule formulations provides uniform eugonadal levels of testosterone for 10-11 weeks in hypogonadal men. BHASIN, S., SWERDLOFF, R. S., STEINER, B., PETERSON, M. A., MERIDORES, T., GALMIRINI, M., PANDIAN, M. R., GOLDBERG, R., and BERMAN, N., J. Clin. Endocrinol. Metab., 1992, 74, (1), 75–83.
  • Novel detection by magnetic microcapsules in the human gastrointestinal tract of cross-linking agents and diet-dependent reactive oxygen species. BINGHAM, S. A., ELLuL, A., CUMMINGS, J. H., and O'NEILL, I., Carcinogenesis, 1992, 13, (4), 683–690.
  • Phytosome: new cosmetic delivery system. BOMBARDELLI, E., Boll. Chim. Farm., 1991, 130, (11), 431–438.
  • Association of cyclosporin to isohexyl cyanoacrylate nanospheres and subsequent release in human plasma in vitro. BONDUELLE, S., FOUCHER, C., LEROUX, J. C., CHOUINARD, F., CADIEUX, C., and LENAERTS, J. Microencapsulation, 1992, 9, (2), 173–182.
  • Induction of calcium transport in liposomes by insulin. BRIMBLE, K. S., and ANANTHANARAYANANAN, V. S., Biochim. Biophys. Acta, 1992, 1105, (2), 319–327.
  • The effect of paracetamol on the hepatic uptake of microparticles in vivo and in vitro. BUHRING, S., HENNICHAUSEN, G., and JoNAs, L., Arch. Toxicol. Supp., 1991, 14, 181–184.
  • The use of liposomes for 'depositing' neurotropic preparations. BURT, A. Iu, LENKOVSKII, F. M., SUKHONOSHCHENKO, L. M., ABRAMOV, TuB., and SACHKOV, V. I., Biull. Eksp. Biol. Med., 1991, 112, (11), 497–499.
  • Cytotoxic effects of some inflammatory mediators on microencapsulated cells. CADIC, C., DUPUY, B., and VITIELLO, S., J. Mater. Sci.: Mater. Med., 1992, 3, (1), 10–13.
  • Transplantation of microencapsulated pancreatic human islets for therapy of diabetes mellitus. A preliminary report. CALAFIORE, R., ASAIO J., 1992, 38, (1), 34–37.
  • A single blind normal volunteer bioavailability study of a new microencapsulated potassium chloride tablet compared with two reference potassium formulations. CAPLAIN, H., DAHAN, R., PAMPHILE, R., and THEBAULT, J. J., Eur. J. Drug Metab. Pharmacokine., 1991, 16, (3), 241–244.
  • Lipid vesicles penetrate into intact skin owing to the transdermal osmotic gradients and hydration force. CEVC, G., and BLUME, G., Biochim. Biophys. Acta, 1992, 1104, (1), 226–232.
  • Biodegradable chitosan matrix for the controlled release of steroids. CHANDY, T., and SHARMA, C. P., Biomater. Artif. Cells Immobilization Biotechnol., 1991, 19, (4), 745–760.
  • Effects of solute concentration on the entrapment of solutes in phospholipid vesicles prepared by freeze-thaw extrusion. CHAPMAN, C. J., ERDAHL, W. E., TAYLOR, R. W., and PFEIFFER, D. R., Chem. Phys. Lipids, 1991, 60, (2), 201–208.
  • Poly(alkyl cyanoacrylate) nanoparticles as polymeric carriers for antisense oligonucleotides. CHAVANY, C., TRUNG LE DOAN, COUVREUR, P., PUISIEUX, F., and HELENE, C., Pharm. Res., 1992, 9, (4), 441–449.
  • In vivo protection against scorpion toxins by liposomal immunization. CHAVEZ-OLORTEGUI, C., AMARA, D. A., ROCHAT, H., Dirsliz, C., and GRANIER, C., Vaccine, 1991, 9, (12), 907–910.
  • Study of fresh microencapsulated islets with polylysine-alginate in xenografts. CHEN, D., BARNEO, L., FIELD, M. J., and VAN DER VLIET, J. A., Transplant. Proc., 1992, 24, (2), 629–630.
  • Evaluation of ion-exchange microspheres as carriers for the anticancer drug doxorubicin: in vitro studies. CHEN, Y., BURTON, M. A., CODDE, J. P., NAPOLI, S., MARTINS, I. J., and GRAY, B. N., J. Pharm. Pharmacol., 1992, 44, (3), 211–215.
  • Detection, localization and kinetics of immunomodulating liposomes in vivo. CLAASSEN, E., Res. Immunol., 1992, 143, (2), 235–241.
  • Post-formation fluorescent labeling of liposomal membranes. In vivo detection, localization and kinetics. CLAASSEN, E., J. Immunol. Methods, 1992, 147, (2), 231–240.
  • Technique for using microencapsulated terpenes in lepidopteran artificial diets. CLANCY, K. M., FOUST, R. D., HUNTSBERGER, T. G., WHITAKER, J. G., and WHITAKER, D. M., J. Chem. Ecol., 1992, 18, (4), 543–560.
  • Biodegradable pseudolatexes: the chemical stability of poly(D, L-lactide) and poly(epsilon-caprolactone) nanoparticles in aqueous media. COFFIN, M. D., and MCGINITY, J. W Pharm. Res., 1992, 9, (2), 200–205.
  • Microencapsulated islet grafts in the BB/E rat: a possible role for cytokines in graft failure. COLE, D. R., WATERFALL, M., MCINTYRE, M., and BAIRD, J. D. Diabetologia, 1992, 35, (3), 231–237.
  • Processing of exogenous liposome-encapsulated antigens in vivo generates class I MHC-restricted T cell responses. COLLINS, D. S., FINDLAY, K., and HARDING, C. V., J. Immunol., 1992, 148, (11), 3336–3341.
  • Targeting of poly(rI)-poly(rC) by fusogenic (F protein) immunoliposomes. COMPAGNON, B., MILHAUD, P., BIENVENUE, A., and PHILIPPOT, J. R., Exp. Cell Res., 1992, 200, (2), 333–338.
  • Use of polylactic acid for the preparation of microparticulate drug delivery systems. CONTI, B., PAVANETTO, F., and GENTA, I., J. Microencapsulation, 1992, 9, (2), 153–166.
  • Intracellular targeting of antibiotics by means of biodegradable nanoparticles. COUVREUR, P., FATTAL, E., ALPHANDARY, H., PUISIEUX, F., and ANDREMONT, A. J. Controlled Release, 1992, 19, (1-3), 259–267.
  • Spectral identification of the electrochromically active carotenoids of Rhodobacter sphaero-ides in chromatophores and reconstituted liposomes. CRIELAARD, W., VAN MOURIK, F., VAN GRONDELLE, R., KONINGS, W. N., and HELLINGWERF, K. J., Biochim. Biophys. Acta, 1992, 1100, (1), 9–14.
  • Stabilization of dry liposomes by carbohydrates. CROWE, L. M., and CROWE, J. H., Dev. Biol. Stand., 1992, 74, 285–294.
  • The use of liposomes in predicting the biological mobility of arsenic compounds. CULLEN, W. R., and NELSON, J., Appl. Organomet. Chem., 1992, 6, (2), 179–183.
  • Activation of Kupffer cell tumoricidal activity by immunomodulators encapsulated in liposomes. DAEMAN, T., Res. Immunol., 1992, 143, (2), 211–214.
  • Absorption and scatter of encapsulated gas filled microspheres: theoretical considerations and some measurements. DE JONG, N., HOFF, L., SKOTLAND, T., and Bom, N., Ultrasonics, 1992, 30, (2), 95–103.
  • Stability of liposomes: effect of the presence of neutral electrolytes on aggregation of LUV-type liposomes with different negative charge. DE LA MAZA, A., and CARRION, F. J. Commun. form Corn. Esp. Deterg., 1992, 23, 349–364.
  • Changes in the permeability of unilamellar liposomes promoted by alkyl betaines with different alkyl chain length. DE LA MAZA, A., PARRA, J. L., GARCIA, M. T., and RIBOSA, Commun. Jorn. Corn. Esp. Deterg., 1992, 23, 365–375.
  • Crosslinking with diacrylylpiperazine (PIP) reduces activation of complement by polyacryl-amide microcapsules. DUPUY, B., GIN, H., CADIC, C., BAQUEY, A., BAQuEY, C., and DUCASSOU, D., Biomater. Arti 1 Cells Immobilization Biotechnol., 1991, 19, (4), 667–674.
  • Evaluation of a new polyacrolein microsphere (acrobead) protein A column: an in vitro study using the blood of patients with immune thrombocytopenia or malignancies. DVILANSKY, A., AHARON, M., RIESENFELD, G., and NATHAN, I., Transfusion, 1992, 32, (3), 210–214.
  • Influence of phospholipid asymmetry on fusion between large unilamellar vesicles. EASTMAN, S. J., HOPE, M. J., WONG, K. F., and CULLIS, P. R., Biochemistry, 1992, 31, (17), 4262–4268.
  • Adsorption of fluorescein dyes on albumin microspheres. EGFARIA, K., and FRIEDMAN, M., Pharm. Res., 1992, 9, (5), 629–635.
  • The stability and functional properties of proteoliposomes mixed with dextran derivatives bearing hydrophobic anchor groups. ELFERINK, M. G., DE WIT, J. G., IN T VELD, G., REICHERT, A., DRIESSEN, A. J., RINGSDORF, H., and KONINGS, W. N., Biochim. Biophys. Acta, 1992, 1106, (1), 23–30.
  • A comparison of two pancreatin microsphere preparations in cystic fibrosis. ELLIOTT, R. B., ESCOBAR, L. C., LEES, H. R., AKROYD, R. M., and REILLY, H. C., N. Z. Med. J., 1992, 105, (930), 107–108.
  • Polymers for biodegradable medical devices. IX: Microencapsulation studies; effects of polymer composition and process parameters on poly(hydroxybutyrate-hydroxyvalerate) microcapsule morphology. EMBLETON, J. K., and TIGHE, B. J., J. Microencapsulation, 1992, 9, (I), 73–87.
  • It's a wrap. Tiny spheres may make oral delivery of proteins a reality (news). ERICKSON, D., Sci. Am., 1992, 266, (2), 108–109.
  • Total sodium-potassium ATPase activity on erythrocyte ghosts in normal pregnancy (letter). EZIMOKHAI, M., and ADAMSON, I., Int. J. Gynaecol. Obstet., 1992, 37, (2), 131–132.
  • Permeability of microcapsules prepared by interfacial polycondensation. FANG-KUANJUN, SHAO-YUN, and WANG-JUSHENG, Zhongguo Fangzhi Daxue Xuebao, 1991, 17, (3), 108–115.
  • Dissolution of compacted aspirin microcapsules. FARID, D. J., and NOKHODCHI, A., Indian J. Pharm Sci, 1991, 53, (5), 222–223.
  • Cationic liposome-mediated transfection with Lipofection reagent. FELGNER, P. L., Methods Mol. Biol., 1991, 7 (Gene Transfer Expression Protocols), 81–89.
  • Isolation and purification of human endometrial stromal and glandular cells using im-munomagnetic microspheres. FERNANDEZ-SHAW, S., SHORTER, S. C., NAISH, C. E., BARLOW, D. H., and STARKEY, P. M., Hum. Reprod., 1992, 7, (2), 156–161.
  • Pharmacokinetic behavior of (57Co)bleomycin liposomes in mice: comparison with the unencapsulated substance. FICHTNER, I., ARNDT, D., RESZKA, R., and GENS, J., Anticancer Drugs, 1991, 2, (6), 555–563.
  • Systemic macrophage activation with liposome-entrapped immunomodulators for therapy of cancer metastasis. FIDLER, I. J., Res. Immunol., 1992, 143, (2), 199–204.
  • Therapy of disseminated melanoma by liposome-activated macrophages. FIDLER, I. J., World J. Surg., 1992, 16, (2), 270–276.
  • Factors affecting the release rate of terbutaline from liposome formulations after intra-tracheal instillation in the guinea pig. FIELDING, R. M., and ABRA, R. M., Pharm. Res., 1992, 9, (2), 220–223.
  • New possibilities for studying complex macromolecular structures of the cell by encasing cells in polyacrylamide microspheres. FILATOV, M. V., VARFOLOMEEV, D. B., and KOTLOVANOVA, L. V., Tsitologiia, 1991, 33, (4), 115–120.
  • Interaction of surfactants with model and biological membranes. VIII. Effect of N-alkyl-N,N,N-trimethylammonium bromides on the autoperoxidation of egg yolk phospha-tidylcholine in liposomes. FILIPEK, J., KOVACS, P., and BALGAVY, P., Biochem. Int., 1992, 26, (1), 79–85.
  • Intracellular delivery of drugs by liposomes containing Po glycoprotin from peripheral nerve myelin into human M21 melanoma cells. FOLDVARI, M., MEZEI, C., and MEZEI, M., J. Pharm. Sci., 1991, 80, (11), 1020–1028.
  • Selective in vivo localization of daunorubicin small unilamellar vesicles in solid tumors. FORSSEN, E. A., COULTER, D. M., and PROFFITT, R. T., Cancer Res., 1992, 52, (12), 3255–3261.
  • Electro-osmophoresis of a charged permeable microcapsule with thin double layer. FRANSAER, J., CELIS, J. P., and Roos, J. R., J. Colloid Interface Sci., 1992, 151, (1), 26–40.
  • MTP-PE in liposomes as a biological response modifier in the treatment of cancer: current status. FROST, H., Biotherapy, 1992, 4, (3), 199–204.
  • Changes in proton-NMR chemical shifts of bis-GMA and its related methacrylates induced by their interaction with phosphatidylcholinecholesterol liposomes. FuilsAwA, S., KADOMA, Y., and KOMODA, Y., Dent. Mater. J., 1991, 10, (2), 121–127.
  • Interaction of rat lecithin-cholesterol acyltransferase with rat apolipoprotein A-I and with lecithin-cholesterol vesicles. FURUKAWA, Y., URANO, T., HIDA, Y., Proil, H., TAKAHASHI, C., and KIMURA, S., J. Biochem. (Tokyo), 1992, 111, (3), 413–418.
  • Interfacial electrochemical studies on ion-complexing phenomena of mixed phospholipid vesicles including crown ether compounds. FURUSAWA, K., OBATA, C., MATSUMURA, H., and KUWAMURA, T., Yukagaku, 1992, 41, (2), 142–148.
  • Unreliability of rate constants derived from a linear transformation of kinetic data, with special reference to cholesterol equilibration between phospholipid vesicles. GmNs, N., Biochem. J., 1992, 283, (2), 537–539.
  • HPLC determination of protocatechuic aldehyde in Salvia miltiorrhiza liposome in plasma. GAO-CHUNFANG, ZHAO-LUHUA, HUANG-HUA and LONG-XINHUA. Zhongguo Yaoke Daxue Xuebao, 1991, 22, (6), 379–380.
  • Sensitive procedures for measuring chloride fluxes mediated by the purified glycine receptor incorporated into phospholipid vesicles. GARCIA-CALVO, M., VALDIVEISO, F., MAYOR, F., Jr., and VAZQUEZ, J., Neurosci. Lett., 1992, 136, (1), 102–104.
  • Phase diagram studies of microcapsule formation using hydroxypropyl methyl cellulose phthalate. GARCIA-ENCINA, G., SANGHVI, S. P., and NAIRN, J. G., Drug Dev. Ind. Pharm., 1992, 18, (5), 561–579.
  • Drug targeting with poly(alkyl) cyanoacrylate) nanoparticles: in vitro activity of primaquine-loaded nanoparticles against intracellular Leishmania donovani. GASPAR, R., OPPERDOES, F. R., PREAT, V., and ROLAND, M., Ann. Trop. Med. Parasitol, 1992, 86, (1), 41–49.
  • An in vivo assessment of aciriamycin-loaded albumin microspheres. GOLDBERG, J. A., WILLMOTT, N., KERR, D. J., SUTHERLAND, C., and MCARDLE, C. S., Br. J. Cancer, 1992, 65, (3), 393–395.
  • Leukocytospermia and function of the seminal vesicles on seminal quality. GONZALES, G. F., KORTEBANI, G., and MAZZOLLI, A. B., Fertil. Steril., 1992, 57, (5), 1058–1065.
  • Use of bromothymol blue to study the complex of methemoglobin with liposomes. GORBENKO, G. P., Ukr. Biokhim. Zh., 1991, 63, (1), 94–98.
  • Preparation of poly(m)-lactide microspheres by emulsion-solvent evaporation, and their clinical applications as a conventional embolic material. GRANDFILS, C., FLANDROY, P., NIHANT, N., BARBETTE, S., JEaomE, R., TEYSSIE, P., and THIBAUT, A., J. Biomed. Mater. Res., 1992, 26, (4), 467–479.
  • Regression of liver metastases following treatment with yttrium-90 microspheres. GRAY, B. N., ANDERSON, J. E., BURTON, M. A., VAN HAZEL, G., CODDE, J., MORGAN, C., and KLEMP, P., Aust. N.Z. Surg., 1992, 62, (2), 105–110.
  • Liposomes as immunological adjuvants: approaches to immunopotentiation including ligand-mediated targeting to macrophages. GREGORIADIS, G., Res. Immunol., 1992, 143, (2), 178–185.
  • Microencapsulation of menadione sodium bisulfite with polydimethylsiloxane by the spray-drying process: characterization by thermal analysis. GRONCHI, P., DEL Rosso, R., CENTOLA, P., and COSENTINO, R. F., J. Microencapsulation, 1992, 9, (2), 183–186.
  • Lipid peroxidation by mineral dusts and fibers: ESR studies of oxygen uptake during peroxidation of lipids in multilamellar liposomes. GULUMIAN, M., and VAN WYK, J. A., S. Afr. J. Sci., 1991, 87, (11-12), 591–594.
  • Influence of the galactosyl ligand structure on the interaction of galactosylated liposomes with mouse peritoneal macrophages. HAENSLER, J., and SCHUBER, F., Glycoconjugate J., 1991, 8, (2), 116–124.
  • Kinetic analysis of tissue distribution of doxorubicin incorporated in liposomes in rats: I. HARASHIMA, H., OHSHIMA, S., MIDORI, Y., YACHI, K., KIKUCHI, H., and KIWADA, H., Biopharm. Drug Dispos., 1992, 13, (3), 155–170.
  • Processing of liposome-encapsulated antigens targeted to specific subcellular compartments. HARDING, C. V., COLLINS, D., and UNANUE, E. R., Res. Immunol., 1992, 143, (2), 188–191.
  • Fluorescent latex microspheres for retrograde tracing of neurons in mouse basal forebrain combined with immunocytochemistry: a methodical approach. HARTIG, W., PAULKE, B., R., and BRUCKNER, G., Acta Histochem. Suppl., 1992, 42, 261–265.
  • Mutual recognition between polymerized liposomes. IV. Polysaccharide-lectin system. HASEGAWA, M., KAxu, T., KURODA, M., ISE, N., and KITANO, H., Biotechnol. Appl. Biochem., 1992, 15, (1), 40–47.
  • Optimized formulation of magnetic chitosan microspheres containing the anticancer agent, oxantrazole. HASSAN, E. E., PARISH, R. C., and GALLO, J. M., Pharm. Res., 1992,9, (3), 390–397.
  • Preparation of compound membrane microcapsule. HATATE, Y UEMURA, Y., SAKAMOTO, S., IwAmA, M., HANO, T., and KAWANO, Y., Kagoshima Daigaku Kogakubu Kenkyu Hokoku, 1991,33, 95–59.
  • An ultrastructural study of the effects of acidic phospholipid substitutions on calcium phosphate precipitation in anionic liposomes. HEYWOOD, B. R., and EANES, E. D., Cala' f. Tissue Int., 1992, 50, (2), 149–156.
  • Liposome interactions with hydroxyapatite crystals: a possible mechanism in the calcification of atherosclerotic plaques. HIRSCH, D., LANDIS, W. J., AZOURY, R., and SARIG, S., Cakif. Tissue Int., 1992, 50, (3), 261–265.
  • Liposome-formulated interleukin-2 as an adjuvant of recombinant HSV glycoprotein gD for the treatment of recurrent genital HSV-2 in guinea-pigs. Ho, R. J., BURKE, R. L., and MERIGAN, T. C., Vaccine, 1992, 10, (4), 209–213.
  • Increase of permeability of synaptosomes and liposomes by the heavy chain of tetanus toxin. HOGY, B., DAUZENROTH, M. E., HUDEL, M., WELLER, U., and HABERMANN, E., Toxicon, 1992, 30, (1), 63–76.
  • Preparation of composite and encapsulated powder particles by dry impact blending. HONDA, H., KIMURA, M., MATSUNO, T., and Koisin, M., Chim. Oggi, 1991, 9, (6), 21–26.
  • Liposomes of prodrug of cyclocytidine. Hou-XiNpu, WANG-JIBO, XU-CHENG, and LI-CHANGLING, Zhongguo Yaoxue Zazhi, 1991, 26, (11), 661–663.
  • Liposomal delivery of soluble protein antigens for class I MHC-mediated antigen presentation. HUANG, L., REDDY, R., NAIR, S. K., ZHOU, F., and ROUSE, B. T., Res. Immunol., 1992, 143, (2), 192–196.
  • Heat-induced drug release rate and maximal targeting index of thermosensitive liposome in tumor-bearing mice. IGA, K., OGAWA, Y., and TOGUCHI, H., Pharm. Res., 1992,9, (5), 658–662.
  • Controlled cisplatin delivery system using poly(D,L-lactic acid). IKE, O., SHImizu, Y., WADA, R., HYON, S. H., and IKADA, Y Biomaterials, 1992, 13, (4), 230–234.
  • FTIR spectroscopy of microsomal lipid peroxidation. IWAOKA, T., and TABATA, F., Spec. Publ., R. Soc. Chem., 1991, 94 (Spectrosc. Biol. Mol.), 179–180.
  • Preparation of multi-phase microspheres of poly(DL-lactic acid) and poly(m-lactic-co-glycolic acid) containing a W/O emulsion by a multiple emulsion solvent evaporation technique. IWATA, M., and MCGINITY, J. W., J. Microencapsulation, 1992, 9, (2), 201–214.
  • Inclusion and fractionated release of nucleic acids using microcapsules made from plant cells. JAESCHKE, A., CECH, D., and EHWALD, R., J. Chromatogr., 1992, 596, (2), 165–171.
  • Interdigitation-fusion vesicles. A new approach for selective opacification of the RES. JANOFF, A. S., MINCHEY, S. R., PERKINS, W. R., BONI, L. T., SELTZER, S. E., ADAMS, D., and BLAU, M., Invest. Radiol., 1991, 26, (Suppl. 1), S167-S168; discussion S175–S176.
  • Transport and decarboxylation of liposomal phosphatidylserine: effect of cations. JASINSKA, R., and ZBOROWSKI, J., Biochim. Biophys. Acta, 1992, 1105, (2), 207–212.
  • Preparation of poly(m-lactide/glycolide) nanoparticles of controlled particle size distribution: application of experimental designs. JULIENNE, M. C., ALONSO, M. J., GOMEZ-AMOZA, J. L., and BENOIT, J. P., Drug Dev. Ind. Pharm., 1992, 18, (10), 1063–1077.
  • Tissue distribution of adriamycin-encapsulated liposomes conjugated with monoclonal antibody. KAWANO, K., Drug Delivery Syst., 1992, 7, (1), 23–30.
  • Control of prolonged drug release, and compression properties of ibuprofen microsponges with acrylic polymer, eudragit RS, by changing their intraparticle porosity. KAWASHIMA, Y., NIWA, T., TAKEUCHI, H., HINO, T., and Pm, Y. Chem. Pharm. Bull., 1992, 40, (1), 196–201.
  • Preparation of powdered phospholipid nanospheres by fluidized-bed granulating in an aqueous system with sugars. KAWASHIMA, Y., HINO, T., TAKEUCHI, H., NIWA, T., KAWAKATSU, E., KAYANO, M., IDA, K., OZAWA, Hand SAKAMOTO, H., Chem. Pharm. Bull., 1992, 40, (2), 472–476.
  • The role of free radicals and the effect of liposomal SOD (superoxide dismutase) in experimental pancreatitis. KENMOCHI, T., ASANO, T., FUKUOKA, T., ARITA, S., NAKAGOURI, T., and IsoNo, K., Suizo, 1991, 6, (6), 589–595.
  • Thermal expandable microcapsules. KIDA, S., Kobunshi, 1991, 40, (4), 248–251.
  • Novel liposome microencapsulation techniques for food applications. KIM-HYE-HYuN, and BAIANU-ION, C., Trends Food Sci. Technol., 1991, 2, (3), 55–61.
  • Stabilization of ascorbic acid by microencapsulation in liposomes. KIRBY, C. J., WHITTLE, C. J., RIGBY, N., COXON, D. T., and LAW, B. A., Int. J. Food Sci. Technol., 1991, 26, (5), 437–449.
  • Sustained-release dosage form of oxolamine citrate: preparation and release kinetics. KIRILMAZ, L., KENDIRCI, A., and GUNERL, T., J. Microencapsulation, 1992, 9, (2), 167–172.
  • Involvement of cytoskeletal proteins in the barrier function of the human erythrocyte membrane. IL Formation of membrane leaks in ghost membranes after limited proteolysis of skeletal proteins by trypsin. KLONK, S., and DEUTICKE, B., Biochim. Biophys. Acta, 1992, 1106, (1), 137–142.
  • Involvement of cytoskeletal proteins in the barrier function of the human erythrocyte membrane. I. Impairment of resealing and formation of aqueous pores in the ghost membrane after modification of SH groups. KLoxic, S., and DEUTICKE, B., Biochim. Biophys. Acta, 1992, 1106, (1), 126–136.
  • Relaxometry of paramagnetic liposomes. KOENIG, S. H., Invest. Radiol., 1991,26, (Suppl. 1), S260-S262; discussion S263–S265.
  • Permeability of liposomal membranes to water: results from the magnetic field dependence of Ti of solvent protons in suspensions of vesicles with entrapped paramagnetic ions. KOENIG, S. H., AHKONG, Q. F., BROWN, R., D., III, LAFLEUR, M., SPILLER, M., UNGER, E., and TILCOCK, C., Magn. Reson. Med., 1992, 23, (2), 275–286.
  • HIV-1 infection of a non-CD4-expressing variant of HUT-78 cells: lack of inhibition by Leu3A antibodies and enhancement by cationic DOTMA liposomes. KONOPKA, K., DAVIS, B. R., and DUZGUNES, N. Adv. Exp. Med. Biol., 1991, 300 (Mech. Speci f. HIV Entry Host Cells), 97–110.
  • Topical liposome drugs to come: what the patent literature tells us. A review. KORTING, H. C., BLECHER, P., SCHAFER- KORTING, M., and WENDEL, A., J. Am. Acad. Dermatol., 1991,25, (6, Pt 1), 1068–1071.
  • Preclinical characterization of iopromide-carrying liposomes. KRAUSE, W., SACFISE, A., WAGNER, S., KOLLENKRICHEN, U., and ROESSLING, G., Invest. Radiol., 1991, 26, (Suppl. 1), S172–S174.
  • Free versus microencapsulated pancreatic islet xenographs producing amelioration of streptozotocin toxicity. KRESTOW, M., Lum, Z. P., TAI, I. T., and SUN, A. M., Biomater. Art if Cells, Immobilization Biotechnol., 1992, 20, (1), 43–51.
  • Microencapsulation of propranolol hydrochloride with ethyl cellulose by solvent evaporation method in liquid paraffin. KU-YOUNG-SOON and KANG-HAE-HYUNG, Nonchong-Han'guk Saenghwal Kwahak Yonguwon, 1991, 48, 109–128.
  • Immobilization of urease into liposomes. KULISHEVA, E., NEICHEV, V., and Dtmxov, R., Dokl. Bulg. Akad. Nauk., 1991, 44, (9), 119–121.
  • Lasing in dye-doped polystyrene microsphere. KUWATA, G. M., and TAKEDA, K., Kotai Butsuri, 1992, 27, (2), 147–151.
  • A novel method for determination of sterility of microcapsules and measurement of viability of encapsulated organisms. KWOK, K. K., and BURGESS, D. J., Pharm. Res., 1992, 9, (3), 410–413.
  • Phospholipid vesicles as drug delivery systems. Part II. A study on kinetic fusion between vesicles containing CDP-choline and dipalmitoylphosphatidylcholine vesicles. LA ROSA, C., GRASSO, D., FRESTA, M., VENTURA, C. A., and PUGLISI, G., Thermochim. Acta, 1992, 198, (1), 181–190.
  • Liposomal amphotericin-B (AmBisome) for treatment of disseminated fungal infections in two infants of very low birth weight. LACKNER, H., SCHWINGER, W., URBAN, C., MULLER, W., RITSCHEL, E., REITERER, F., KUTTNIG-HAIM, M. URLESBERGER, B., and HAVER, C., Pediatrics, 1992, 89, (6, Pt 2), 1259–1261.
  • The antioxidant activity of ubiquino1-3 in homogeneous solution and in liposomes. LANDI, L., CABRINI, L., FIORENTINI, D., STEFANELLI, C., and PEDULLI, G. F., Chem. Phys. Lipids, 1992, 61, (2), 121–130.
  • Protective effect of liposome-entrapped superoxide dismutase and catalase on bleomycin-induced lung injury in rats. II. Phospholipids of the lung surfactant. LED WOZYW, A., Acta Physiol. Hung., 1991, 78, (2), 157–162.
  • The use of albumin microspheres in the treatment of carrageenan-induced inflammation in the rat. LEWIS, D. A., FIELD, W. N., HAYES, K., and ALPAR, H. O., J. Pharm. Pharmacol., 1992, 44, (3), 271–274.
  • Permeability study of phospholipid liposomes prepared by reverse phase evaporation method. LIM-KEUNPOONG, and CHoi-M-YuNG-UN, Han'guk Saenghwa Hakhoechi, 1991, 24,(6), 609–616.
  • Biodistribution and immunotargetability of ganglioside-stabilized dioleoylphosphatidyleth-anolamine liposomes. LITZINGER, D. C., and HUANG, L., Biochim. Biophys. Acta, 1992, 1104, (1), 179–187.
  • Role of liposome size, and RES blockade in controlling bimlistribution and tumor uptake of GM1-containing liposomes. Liu, D., MORI, A., and HUANG, L., Biochim. Biophys. Acta, 1992, 1104, (1), 95–101.
  • Co-reconstitution of choline dehydrogenase and submitochondrial preparation with lipo-somes. LIU-LIN, HUANG-KUN and LIN-QisHui. Shengtvu Huaxue Yu Shengtvu Wuli Xuebao, 1991, 23, (1), 62–69.
  • Lipophilic N-acylpyrazinamide derivatives: synthesis, physicochemical characterization, liposome incorporation, and in vitro activity against Mycobacterium avium-intracellulare. Liu, Z. Z., Guo, X. D., STRAUB, L. E., ERDOS, G., PRANKERD, R. J., GONZALEZ-ROTHI, R, J., and SCHREIER, H., Drug Des. Discovery, 1991, 8, (1), 57-67_
  • Liposome-mediated delivery stimulates a class I-restricted cytotoxic T cell response to soluble antigen. LOPES, L. M., and CHAIN, B. M. Eur. J. Immunol., 1992, 22, (1), 287–290.
  • Orientational order and vesicle shape. LUBENSKY, T. C., and PROST, J., J. Phys. II, 1992, 2, (3), 371–382.
  • Colloidal drug delivery systems for the eye. A comparison of the efficacy of three different polymers: poly(isobutyl cyanoacrylate), poly(lactic-co-glycolic acid), poly(epsilon-caprolactone). MARCHAL-HEUSSLER, L., FESSI, H., DEVISSAGUET, J. P., HOFFMAN, M., and MAINCENT, P., STP Pharma Sci., 1992, 2, (1), 98–104.
  • Bioadhesive liposomes as topical drug delivery systems: molecular and cellular studies. MARGALIT, R., OKON, M., YERUSHALMI, N., and AVIDOR, E., J. Controlled Release, 1992, 19, (1-3), 275–287.
  • Methyl alpha-(hydroxymethyl)acrylate microspheres: design, synthesis, characterization, and use. MARCEL, S., TENANBAUM, M., and FISHER, I., J. Colloid Interface Sci., 1992, 150, (1), 22–35.
  • Encapsulation of doxorubicin in neutral liposomes by passive methods: evidence of drug-lipid interaction at neutral pH. MARTI, A., ARMENGOL, X., ESTELRICH, J., and HERNANDEZ BORRELL, J., J. Microencapsulation, 1992, 9, (2), 191–200.
  • Therapeutic effects of liposomal Adriamycin in combination with tumor necrosis factor-alpha. MARCO, Y., KONNO, H., and BABA, S., J. Surg. Oncol., 1992, 49, (1), 20–24.
  • Prolongation of canine epidural anesthesia by liposome encapsulation of lidocaine. MASHIMO, T., UCHIDA, I., PAK, M., SHIBATA, A., NISHIMURA, S., INAGAKI, Y., and YOSHIYA, I., Anesth. Analg., 1992, 74, (6), 827–834.
  • Polyanhydride microspheres. IV. Morphology, and characterization of systems made by spray drying. MATHIOWITZ, E., BERNSTEIN, H., GIANNOS, S., DOR, P., TUREK, T., and LANCER, R., J. Appl. Polym. Sci., 1992, 45, (1), 125–134.
  • Pharmacokinetics and antitumor activity of epirubicin encapsulated in long-circulating liposomes incorporating a polyethylene glycol-derivatized phospholipid. MAYHEW, E. G., LASIC, D., BABBAR, S., and MARTIN, F. J., Int. J. Cancer, 1992, 51, (2), 302–309.
  • Effect of lipid physical state on the rate of peroxidation of liposomes. MCLEAN, L. R., and HAGAMAN, K. A., Free Radic. Biol. Med., 1992, 12, (2), 113–119.
  • Increased effectiveness of liposome-encapsulated doxorubicin in multidrug-resistant-transgenic mice compared with free doxorubicin. MICKISCH, G. H., RAHMAN, A., PASTAN, I., and GOTTESMAN, M. M., J. Natl. Cancer Inst., 1992, 84, (10), 804–805
  • Liposomes enhance the oral availability of certain water-insoluble drugs. MicKLus, M. J., Ann. N.Y. Acad. Sci., 1991, 618 (Temporal Control Drug Delivery), 589–591.
  • Organ distribution of liposomal formulations following intracarotid infusion in rats. Micimus, M. J., GREIG, N. H., TUNG, J., and RAPOPORT, S. I., Biochim. Biophys. Acta, 1992, 1124, (1), 7–12.
  • Strategy for large intestinal mucosa targeting by suppositories with dispersed microcapsules containing 5-aminosalicylic acid. MIYAKAWA, T., UCHIDA, T., SEKIYA, N., KIM-NAK-SE0, and GOTO, S., Drug Delivery Syst., 1992, 7, (1), 57–62.
  • Beneficial effects of naftidrofuryl oxalate on brain regional energy metabolism after microsphere-induced cerebral embolism. MIYAKE, K., TAGUCHI, T., TANONAKA, K., HORIGUCHI, T., TAKAGI, N., and TAKEO, S., J. Pharmacol. Exp. Ther., 1992, 260, (3), 1058–1066.
  • Preparation and surface characterization of carboxymethylchitin-incorporated submicron bilayer-lipid membrane artificial cells (liposomes) encapsulating hemoglobin. MOBED, M., and CHANG, T. M., Biomater. Artif. Cells Immobilization Biotechnol., 1991, 19,(4), 731–744.
  • Purification and characterization of liposomes encapsulating hemoglobin as potential blood substitutes. MBOED, M., NISHIYA, T., and CHANG, T. M. S. Biomater. Arti f. Cells, Immobilization Biotechnol., 1992, 20, (1), 53–70.
  • Decreased serum level of tumor necrosis factor in animals treated with lipopolysaccharide and liposomes containing phosphatidylserine MONASTRA, G., and BRUIN, A., Lymphokine Cytokine Res., 1992, 11, (1), 39–43.
  • Use of fluorescent microspheres in studies of the effects of inhaled radioactive materials on the phagocytic competence of alveolar macrophages. MORGAN, A., TALBOT, R. J., and TAYA, A., Radiat. Prot. Dosim., 1991, 38, (1-3), 205–212.
  • Relationships between manufacturing parameters and pharmaceutical-technological re-quirements on biodegradable microparticles. Part 3: Pharmaceutical and technological investigations on the particle size distribution of local anesthetics containing biodegrad-able microspheres. THOMA, K., and SCHLUETERMANN, B., Pharmazie, 1992, 47, (3), 198–202.
  • Transfer of liposome containing dolichol into isolated hepatocytes. ToLLsom, 0., CHOJNACKI, T., and DALINER, G., Lipids, 1992, 27, (4), 248–254.
  • Effect of fatty acyl domain of phospholipids on the membrane-channel formation of Staphylococcus aureus alpha-toxin in liposome membrane. TOMITA, T., WATANABE, M., and YASUDA, T., Biochim. Biophys. Acta, 1992, 1104, (2), 325–330.
  • Preparation and in vitro antiviral activity of liposomes of lipophilic esters of acyclovir. TONG, P., Hou, X. P., and SHAO, S., ZHANG, Y. M., and ZHANG, C. H., Yaoxue Xuebao, 1992,27, (1), 15–21.
  • Polymer encapsulated neurotransmitter secreting cells. Potential treatment for Parkinson's disease. TRESCO, P. A., WINN, S. R., and AEBISCHER, P., ASAIO, J., 1992, 38, (1), 17–23.
  • Aminophylline targeting to lung: optimization of the size and drug loading of albumin microspheres. TRIPATHI, K. P., and SINGH, J., J. Microencapsulation, 1992, 9, (2), 229–235.
  • Regulation of the tetracycline hydrochloride release from polyacrylate microspheres. Part 1. TSANKOV, S., LAMBOV, N., and MINKOV, E., Pharmazie, 1992, 47, (2), 125–128.
  • Evaluation of microcapsules. XXX. Utility of mixture of commercially available polymers as constituents of sustained-release microcapsules containing cefadroxil or theophylline. UCHIDA, T., YASUTAKE, T., and GOTO, S., Chem. Pharm. Bull., 1992, 40, (2), 463–466.
  • Metabolic activity of CHO fibroblasts in HEMA-MMA microcapsules. ULUDAG, H., and SEFTON, M. V., Biotechnol. Bioeng., 1992, 39, (6), 672–678.
  • Preparation and evaluation of temperature-sensitive liposomes containing doxorubicin (DXR) by pH gradient method. UNEZAKI, S., MATSUMURA, M., 01ITANI, Y., TAKAHASHI, N., MARUYAMA, K., OKAMOTO, A., and IWATSURU, M., Drug Delivery Syst., 1992, 7, (1), 37–41.
  • Studies on tumor selective targeting by temperature-sensitive liposomes encapsulated doxorubicin with local hyperthermia. UNEZAKI, S., MATSUMURA, M., TAKAHASHI, H., MAE, A., OHTANI, Y., TAKAHASHI, T., and TAKAHASHI, N., Byoin Yakugaku, 1992, 18, (1), 85–91.
  • Liposomes as MR contrast agents: pros and cons. UNGER, E., SHEN, D. K., Wu, G. L., and FRITZ, T., Magn. Reson. Med., 1991, 22, (2), 304–308; discussion 313.
  • HPLC analysis of estrone released from poly(lactic acid) microspheres. UPADRASHTA, S. M., PARIKFI, B. V., and NUESSLE, N. 0., Anal. Lett., 1992, 25, (3), 535–542.
  • In situ activation of mouse lung macrophages by coadministration of liposomes containing the lipopeptide CGP 31362 and interleukin 2 involves interaction with T. lymphocytes and natural killer cells. UTSUGI, T., DINNEY, C. P., KILLION, J. J., BROWN, D., and FIDI.ER, I. J., Lymphokine Cytokme Res., 1991, 10, (6), 487–493.
  • Reconstitution of glucosylceramidase on binding to acidic phospholipid-containing vesicles. VACCARO, A. M., TATT1, M., CIAFFONI, F., SALVIOLI, R., and RONCAIOLI, P., Biochim. Biophys. Acta, 1992, 1119, (3), 239–246.
  • Tissue distribution and in vivo immunosuppressive activity of liposomal cyclosporine. VADIEI, K., LOPEZ-BERESTEIN, G., PEREZ-SOLER, R., and LUKE, D. R., Drug Metab. Dispos., 1991, 19, (6), 1147–1151.
  • Maltose/proton co-transport in Saccharotnyces cerevisiae. Comparative study with cells and plasma membrane vesicles. VAN LEEUWEN, C. C., WEUSTHUIS, R. A., POSTMA, E., VAN DEN BROEK, P. J., and VAN DIJKEN, J. P., Biochem. J., 1992, 284, (2), 441–445.
  • Liposome-mediated elimination of macrophages. VAN RoolJEN, N., Res. Immunol., 1992, 143, (2), 215–219.
  • Liposomes as an in vivo tool to study and manipulate macrophage function. VAN RoolJEN, N. Res. Immunol., 1992, 143, (2), 177–178.
  • Rapid loss and restoration of lipid asymmetry by different pathways in resealed erythrocyte ghosts. VERHOVEN, B., SCHLEGEL, R. A., and WILLIAMSON, P., Biochim. Biophys. Acta, 1992,1104, (1), 15–23.
  • Adjuvant effects of liposomes containing lipid A: enhancement of liposomal antigen present-ation and recruitment of macrophages. VERMA, J. N., RAO, M., AMSELEM, S., KRZYCH, U., ALVING, C. R., GREEN, S. J., and WASSER, N. M., Infect. Immun., 1992, 60, (6), 2438–2444.
  • Phagocytosis of liposoles by macrophages: intracellular fate of liposomal malaria antigen. VERMA, J. N., WASSEF, N. M., WIRTZ, R. A., ATKINSON, C. T., AIKAWA, M., Loomis, L. D., and ALVING, C. R., Biochim. Biophys. Acta, 1991, 1066, (2), 229–238.
  • Determination of the partition of the tetramisole derivative ( + - )-5,6-dihydro-6-pheny1-2-n-propylimidazo(2,1-b)thiazole into liposomal membranes by fluorescence quenching of the membrane probe 8-(2-anthryl)octanoic acid. VERMEIR, M., and BOENS, N., Eur. Biophys. J., 1992, 21, (1), 47–56.
  • Partitioning of ( + - )-5,6-dihydro-6-pheny1-2-n-alkyl-imidazo(2,1-b) thiazoles into large uni-lamellar liposomes: a steady-state fluorescence quenching study. VERMEIR, M., and BOENS, N., Biochim. Biophys. Acta, 1992, 1104, (1), 63–72.
  • Interaction of 7-n-alkoxycoumarins with cytochrome P450(2) and their partitioning into liposomal membranes. Assessment of methods for determination of membrane partition coefficients. VERMEIR, M., BOENS, N., and HEIRWEGH, K. P., Biochem. J., 1992, 284, (2), 483–490.
  • Polymer-coated albumin microspheres as carriers for intravascular tumor targeting of cisplatin. VERRIJK, R., SMOLDERS, L. J. H., MuVIE, J. G., and BEGG, A. C. Cancer Chemother. Pharmacol., 1991, 29, (2), 117–121.
  • The antitumor activity of liposomal aclarubicin in vitro and in vivo. VIADRO, M. M., and NAVASHIN, S. M., Biull. Eksp. Biol. Med., 1991, 112, (11), 523–525.
  • In vitro evaluation of spray-dried mucoadhesive microspheres for nasal administration. VIDGREN, P., VIDGREN, M., ARPPE, J., HAKULI, T., LAINE, E., and PARONEN, P., Drug. Den. Ind. Pharm., 1992, 18, (5), 581–597.
  • Sodium chloride-induced aggregation of dipalmitoylphosphatidylglycerol small unilamellar vesicles with varying amounts of incorporated cholesterol. VIRDEN, J. W., and BERG, J. C., Langmuir, 1992, 8, (6), 1532–1537.
  • In vitro study of the cytotoxicity of inflammation mediators secreted around microen-capsulated cells. VITIELLO, S., CADIC, C., and DUPUY, B., C. R. Seances Soc. Biol. Fil., 1991, 185, (5), 338–344.
  • Immunoprotection obtained with microcapsules does not prevent cytotoxicity of small inflammatory mediators (letter). Horm. Metab. Res., 1992, 24, (2), 96.
  • Liposomes for allergy immunotherapy? (editorial). WALLS, A. F., Clin, Exp. Allergy, 1992, 22, (1), 1–2.
  • Spray drying as a process for microencapsulation and the effect of different coating polymers. WAN, L. S. C., HENG, P. W. S., and CHIA, C. G. H., Drug Den. Ind. Pharm., 1992, 18, (9), 997–1011.
  • Hepatic arterial chemoembolization with CDDP microcapsules. Experimental studies. WANG, Y., Wu, M. C., and ZHANG, X. H., Chin. Med. J. (Engl.), 1992, 105, (2), 120–125.
  • Increased accumulation of drugs in multidrug-resistant cells induced by liposomes. WARREN, L., JARDILLIER, J. C., MALARSKA, A., and AKELI, M. G., Cancer Res., 1992, 52, (11), 3241–3245.
  • Drug targeting in magnetic resonance imaging. WEISSLEDER, R., BOGDANOV, A., and PAPISOV, M., Magn. Reson. Q., 1992, 8, (I), 55–63.
  • A novel two step procedure for immobilizing living cells in microcapsules for improving xenograft survival. WoNG, H., and CHANG, T. M., Biomater. Artif. Cells Immobilization Biotechnol., 1991, 19, (4), 687–697.
  • The microencapsulation of cells within alginate poly-L-lysine microcapsules prepared with the standard single step drop technique: histologically identified membrane imperfec-tions and the associated graft rejection. WONG, H., and CHANG, T. M., Biomater. Arti f. Cells Immobilization Biotechnol., 1991, 19, (4), 675–686.
  • Versatility in lipid compositions showing prolonged circulation with sterically stabilized liposomes. WOODLE, M. C., MATTHAY, K. K., NEWMAN, M. S., HIDAYAT, J. E., COLLINS, L. R., BEDEMANN, C., MARTIN, F. J., and PAPAHADJOPOULOS, D., Biochim. Biophys. Acta, 1992, 1105, (2), 193–200.
  • Sterically stabilized liposomes: reduction in electrophoretic mobility but not electrostatic surface potential. WOODLE, M. C., COLLINS, L. R., SPONSLER, E., KOSSOVSKY, N., PAPAHADJOPOULOS, D., and MARTIN, F. J., Biophys. J., 1992, 61, (4), 902–910.
  • Prolonged systemic delivery of peptide drugs by long-circulating liposomes: illustration with vasopressin in the Brattleboro rat. WOODLE, M. C., STORM, G., NEWMAN, M. S., JEKOT, J. J., COLLINS, L. R., MARTIN, F. J., and SZOKA, F. C. Jr., Pharm. Res., 1992, 9, (2), 260–265.
  • The preparation and stability of liposome-encapsulated Ara-A. XUE, Y., Y., and WENG, G. Y Yaoxue Xuebao, 1992, 27, (1), 74–80.
  • Biocompatibility studies of naltrexone sustained release formulations. YAMAGUCHI, K., and ANDERSON, J. M., J. Controlled Release, 1992, 19, (1-3), 299–314.
  • Microcapsulated latent hardener "NOVACURE" for one-part epoxy resin system. IV. YAMAMOTO, J., and FuKuotca, M., Kotingu Jiho, 1991, 190, 1–10.
  • Hepatoma cell targetability of liposomes coated with polysaccharides bearing galactose groups. YAMATOTO, M., SEGAWA, T., IWATA, A., KADOHARA, T., IzAwA, K., KADOTA, T., TSUCHIYA, R., KONDO, S., and OHBATA, Y., Drug Delivery Syst., 1991, 6, (5), 355–359.
  • Reconstitution of Na+ /11+-antiporter of bovine renal brush-border membrane into proteolipo-somes and detection of a 110 kDa protein cross-reactive with antibodies against a human Na /H +-antiporter partial peptide in antiport-active fractions after partial fractionation. YAMASHITA, T., and KAWAKITA, M., J. Biochem (Tokyo), 1992, 111, (2), 162–167.
  • Studies of alcohol-induced interdigitated gel phase in phosphatidylcholine multilamellar vesicles by the excimer method. YAMAZAKI, M., MIYAZU, M., and ASANO, T., Biochim. Biophys. Acta, 1992, 1106, (1), 94–98.
  • Studies on carbohydrate-bonding proteins using liposome-based systems—I. Preparation of neoglycoprotein-conjugated liposomes and the feasibility of their use as drug-targeting devices. YAmAzAxi, N., KojiMA, S., GABIUS, S., and GABIUS, H. J., Int. J. Biochem., 1992,24, (1), 99–104.
  • A study of the stability of W/O/W multiple emulsions. YAN-NIANXI, ZHANG-MINGZU, and NI-PEIHONG., J. Microencapsulation, 1992, 9, (2), 143–151.
  • Preparation of liposome-encapsulated superoxide dismutase and its pharmacokinetics. ZHANG-JIAN, and ZHANG-TIANMIN. Zhongguo Yiyao Gongye Zazhi, 1991, 22, (7), 296-298, 315. Targeted delivery of DNA by liposomes and polymers. ZHOU-XIAOHUAI and HUANG, L., J. Controlled Release, 1992, 19, (1-3), 269–274.
  • Temperature sensitive liposome encapsulated adriamycin combined with hepatic artery embolization. Zou, Y. Y., Gu, X. Q., and HORIKOSHI, I. M., Yao-Hsueh-Hsueh-Pao, 1991, 26, (8), 622–626.
  • Targeting liver tumors by administering liposomal doxorubicin into the hepatic artery. Zou, Y., HORIKOSHI, I., UENO, M., Gu, X., and PEREZ-SOLER, R., Int. J. Cancer, 1992, 51, (2), 232–237.
  • Mechanism of the spontaneous transfer of unconjugated bilirubin between small unilamellar phosphatidylcholine vesicles. ZUCKER, S. D., STORCH, J., ZEIDEL, M. L., and GOLLAN, J. L., Biochemistry, 1992, 31, (12), 3184–3192.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.